Renata Crome

Renata started her career in academia at St Thomas’s Hospital, London working on cardiovascular research and heart transplantation. She joined the Drug Development Department at Roche, gaining over 30 years extensive experience in the scientific and clinical development, regulatory approval and commercialisation of new medicines. The majority of Renata’s pharmaceutical career was spent in early clinical development, initially as a Clinical Pharmacologist in the CVS, Infectious Diseases, and CNS therapeutic areas.

As a Project Leader, she led project teams for Roche’s key projects including Tamiflu the influenza drug, Avastin and Obinutuzumab Oncology molecules. Renata’s most recent role at Roche was as the Global Head of Early Development Clinical Operations and Deputy Head of Early Development. She joined Cancer Research UK in 2015 to head up the Study, Project and Portfolio Management Group management group responsible for the in-licensing and development of a portfolio of ~ 25 oncology products .

Renata is now a Senior Scientific advisor with the Avance Life Sciences consultancy , a director and trustee of the PTEN Research Foundation, holds a number of Non-Executive Directorships, and was recently elected to honorary membership of the Faculty of Pharmaceutical Medicine. Latterly Renata was called upon by the UK government to form the UKRI sponsored team of pharmaceutical experts to develop treatments for Covid-19.